Blood-Brain Barrier-Penetrating Neuroprotective Compound for Stroke
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current neuroprotective agents for stroke are inadequate due to the complexity of stroke pathogenesis, leading to high incidence and significant disability with no ideal treatment available.
Innovation Solution
Development of a novel compound with neuroprotective properties that can pass through the blood-brain barrier, offering potential treatment for stroke and pain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If currently commonly used neuroprotective agents (free radical scavengers, glutamate antagonists, calcium channel antagonists, cell membrane stabilizers) are used, then some neuroprotective effect is achieved, but due to the complexity of stroke pathogenesis, no ideal neuroprotective agent is available and treatment effectiveness remains insufficient
Solution Approach 1:
The compound of formula I is designed to simultaneously target multiple stroke pathogenesis mechanisms including free radical scavenging, glutamate antagonism, calcium channel blockade, and cell membrane stabilization, making a single agent that performs multiple neuroprotective functions that were previously achieved only through combination therapies
2Reliability
If new neuroprotective agents are developed to address complex stroke pathogenesis, then treatment effectiveness may be improved, but the complexity of developing agents that can effectively address multiple pathogenesis mechanisms increases
Solution Approach 1:
The patent combines multiple pharmacophores with distinct neuroprotective activities into a single molecular entity of formula I, merging the functions of free radical scavengers, glutamate antagonists, calcium channel antagonists, and cell membrane stabilizers into one compound that addresses multiple aspects of stroke pathogenesis simultaneously
Data Source
AI summary
Disclosed are a compound having a neuroprotective effect, a preparation method therefor and a use thereof. Specifically, the compound has the structure shown by formula I, the definition of each group and substituent being as described in the description. Further disclosed are a preparation method for the compound and a use thereof for neuroprotection.